PreprintAll rights reservedmedRxiv29 Oct 2026

Multi-modal data Integration for Metastatic Risk Prediction of AJCC Stage I/II Melanomas: Results from the Population-based Dutch Early-stage Melanoma Study (D-ESMEL)

J. Ouwerkerk¹
T. Kerkour
C. Zhou
A. Mooyaart
A. Stubbs
M. Reinders
Y. Li
L. Hollestein

¹Department of Pathology and Clinical Bioinformatics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands

Primary Nodular Melanomas May Represent Epidermotropic Melanoma Metastases Diagnosed at a Later Stage.
Félix Khoa Pham, Marie Danset, Olivier Harou +3
Dermatology practical & conceptual31 Jul 2026Peer-reviewedCC BY-NCFull textOncologyEurope PMC
Decidual-Like Natural Killer Cells Are Enriched in Melanomas and Acquire CD9 Through Melanoma Cell Contact
N. A. Vandeven, C. E. Collora, C. Muckle +11
medRxiv18 Sep 2026PreprintAll rights reservedFull textOncologymedRxiv
Utility of Chemotherapy for Metastatic Melanoma in the Contemporary Era and Experience with Modified Vinblastine–Cisplatin–Temozolomide at a Tertiary Care Center
Woo Kyung Lee Doolittle, Rohit Rao, Malena Johnson +4
Biomedicines1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
1076 Patient-derived organoids reveal tumor-restricted noncanonical HLA-I antigen candidates in low mutation burden metastatic melanoma
David Scheinberg, Chenyang Zhan, Wilson H McKerrow +4
Journal for ImmunoTherapy of Cancer4 Nov 2026Peer-reviewedCC BYFull textOncologyDOAJ
114 CXCL6 emerges as a novel marker of an immunosuppressive, angiogenic, and epithelial-mesenchymal transition (EMT)-enriched metastatic program in uveal melanoma (UM)
Justin Moser, Jose Lutzky, Andrew Elliott +7
Journal for ImmunoTherapy of Cancer6 Nov 2026Peer-reviewedCC BYFull textImmunology OncologyDOAJ

Cite

BibTeX

@misc{ouwerkerk2026multimodal,
  title = {{Multi-modal data Integration for Metastatic Risk Prediction of AJCC Stage I/II Melanomas: Results from the Population-based Dutch Early-stage Melanoma Study (D-ESMEL)}},
  author = {J. Ouwerkerk and T. Kerkour and C. Zhou and A. Mooyaart and A. Stubbs and M. Reinders and Y. Li and L. Hollestein},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.29.26366608},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.29.26366608v1},
}

RIS

TY  - UNPB
TI  - Multi-modal data Integration for Metastatic Risk Prediction of AJCC Stage I/II Melanomas: Results from the Population-based Dutch Early-stage Melanoma Study (D-ESMEL)
AU  - J. Ouwerkerk
AU  - T. Kerkour
AU  - C. Zhou
AU  - A. Mooyaart
AU  - A. Stubbs
AU  - M. Reinders
AU  - Y. Li
AU  - L. Hollestein
PY  - 2026
DA  - 2026/10/29
PB  - medRxiv
DO  - 10.64898/2026.10.29.26366608
UR  - https://www.medrxiv.org/content/10.64898/2026.10.29.26366608v1
ER  -

Related

Cite